KIRKLAND, Washington, March 9 /PRNewswire/ --
ProteoTech Inc. announced today that both Dr. Alan D. Snow, Chairman, President CSO, and Dr. Luke Esposito, Director of In Vitro Screening, will present at the 9th International Conference for Alzheimer's and Parkinson's Diseases, to be held in Prague, Czech Republic, March 11-15, 2009. On Sunday March 15, Dr. Alan D. Snow will give an oral presentation discussing promising results pertaining to ProteoTech's current Phase 1A human clinical trial with the small molecule Exebryl-1(R) for the treatment of mild-to-moderate Alzheimer's disease. Dr. Snow's talk is entitled: Exebryl-1(R): A Novel Small Molecule Currently in Human Clinical Trials as a Disease-Modifying Drug for the Treatment of Alzheimer's Disease.